When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALXN - European advisory group backs Alexion's Soliris for rare inflammatory disorder
Alexion Pharmaceuticals Inc.
The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval of Alexion Pharmaceuticals' (NASDAQ:ALXN) Soliris (eculizumab) for the treatment of adult patients with relapsing anti-aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder, a rare autoimmune disease characterized by inflammation of the optic nerve and spinal cord.
More news on: Alexion Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,